This edition of the HDYO Research Video Series, we look at the article, SURVEYOR opens the door for drugs that treat cognition. Sage Therapeutics announced results from SURVEYOR, a trial that looked at cognitive changes in people with HD, and tested short-term safety of dalzanemdor. The study was small but met key goals, and additional trials are in progress.
To read complete article, visit: en.hdbuzz.net/369
The HDYO Research Video Series is sponsored by Roche, Sage Therapeutics, Teva Pharmaceutical, uniQure, Wave Life Sciences, Griffin Foundation and Neurocrine Biosciences.
Негізгі бет HDYO Research Video Series: SURVEYOR opens the door for drugs that treat cognition
Пікірлер